Some stocks are up on news of big biotech mergers, but others are down on hearing of the latest difficulties of gene therapy.
January 2018 Review Show with Nathan and…
Some stocks are up on news of big biotech mergers, but others are down on hearing of the latest difficulties of gene therapy.